Product Information
DEXAMETHASONE 4 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1928 per EA under NDC 00904726661. Its NADAC has been published 189 times since Feb 22, 2023.
FDA first approved this application on Oct 14, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904726661
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXAMETHASONEApproval Type
Generic (ANDA)
FDA Application
ANDA215106FDA Approved
10/14/2021
TE Code
AB
On Market Since
9/1/2021
Pharmacological Classes
Price Statistics
The NADAC for DEXAMETHASONE 4 MG TABLET has been published 189 times since Feb 22, 2023, and over the history we have for it it has declined 46.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1928 per EA |
|---|---|
| All-time high | $0.5087 (Dec 13, 2023) |
| All-time low | $0.1876 (Aug 19, 2026) |
| 52-week high | $0.2599 |
| 52-week low | $0.1876 |
| Median price | $0.2929 |
| Average price | $0.2933 |
| Largest weekly change | +47.6% (Nov 22, 2023) |
| Weeks tracked | 189 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dexamethasone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXAMETHASONE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DEXAMETHASONE 4 MG TABLET, manufactured by Major Pharmaceuticals, is $0.1928 per EA (NDC 00904726661), effective Sep 30, 2026.
How has the price of DEXAMETHASONE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for DEXAMETHASONE 4 MG TABLET has declined 46.4%. It has been tracked across 189 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for DEXAMETHASONE 4 MG TABLET?
Since Feb 22, 2023, the NADAC for DEXAMETHASONE 4 MG TABLET has ranged from a low of $0.1876 (Aug 19, 2026) to a high of $0.5087 (Dec 13, 2023), with a median of $0.2929 per EA.
Are there cheaper alternatives to DEXAMETHASONE 4 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXAMETHASONE 4 MG TABLET, is $0.1876 per EA — about 3% below DEXAMETHASONE 4 MG TABLET.
Who manufactures DEXAMETHASONE 4 MG TABLET?
DEXAMETHASONE 4 MG TABLET (NDC 00904726661) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.